dremilymcd.bsky.social
Associate prof internal medicine @mcgillU Montreal, Canada. Director, Canadian Med Appropriateness and Deprescribing Network. ID trials. Editor at CMI Comms.
👤 Joined on 16 November 2024
Followers
Following
Total Posts
@dremilymcd.bsky.social🎙️ Just published Communicable E62: the 'prose' and cons of the POET trial – early oral antibiotic switch for endocarditis Hosted by Emily McDonald & Josh Davis with invited guests Henning Bundgaard and Sami El-Dalati 🌟 Listen on #Communicable: https://share.transistor.fm/s/d5eb49ac #IDSky
Show Post📣 More evidence that less is probably more: During a global shortage of #bloodculture bottles, Japanese hospitals reduced the number of sets drawn per patient. Contamination rates went down, while detection rates of real pathogens did not. #IDSky #clinmicro www.cmi-comms.org/article/S295...
Show Post📣 New #Communicable drops Mon 05 Oct! Marc Bonten & Emily McDonald are joined by Valentijn Schweitzer & Sylvain Lother to discuss the use of macrolides in community-acquired pneumonia and how the available evidence informs clinical practice. Tune in! #IDSky #clinmicro
Show Post🎙️ Just published Communicable E64: Getting micro on macrolides for community-acquired pneumonia Hosted by Marc Bonten & Emily McDonald with invited guests Valentijn Schweitzer & Sylvain Lother 🌟 Listen on #Communicable: https://share.transistor.fm/s/deec5589 #IDSky #clinmicro
Show Post📣 New #Communicable drops Mon 19 Oct! Emily McDonald and Angela Huttner sit down for another Quarterly catch-up, discussing four recent RCTs across different patient populations and infections, and what the findings mean for clinical practice. #IDSky #clinmicro
Show Post